Clinical Trials Browser

Phase 1 × LEO 43204 × Clear all

NCT02650505 2025-02-24

A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

Phase 1 Completed

Keratosis, Actinic